Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Metastatic Castration Resistant Prostate Cancer × rucaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 2 Neoplasms 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Metastatic Castration Resistant Prostate Cancer 1 Genital Neoplasms, Female 1 Fallopian Tube Neoplasms 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1

Interventions

enzalutamide 4 rucaparib 1 abiraterone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04179396 2023-06-29

RAMP

pharmaand GmbH

Phase 1 Completed

8 enrolled 8 charts

Metastatic Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡